Article
Pre-diagnostic clonal hematopoiesis of indeterminate potential among patients with a primary cancer and risk of second cancers.
Leukemia - 1 Jun 2026
Liu Xinyuan, Adami Hans-Olov, Boberg Erik, Smedby Karin E, Wei Hui, Fang Fang, Liu Qianwei
Abstract excerpt
Clonal hematopoiesis of indeterminate potential (CHIP) is associated with an elevated risk of hematologic and solid cancers. We performed a prospective cohort study, including 63690 patients with a first diagnosis of primary cancer in the UK Biobank during 2006 to 2022, to investigate the association of pre-diagnostic CHIP with future risk of second cancers. Cox regression was employed to assess the association...
Topics
Join the communities discussing this publication.
